Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 1986; Volume 14,Issue 2
  • You have access
    N-dephenylation of CERM 3517 (mociprazine) in beagle dogs. A mass spectrometric determination.
    J F Pognat, A Enreille, J L Chabard, N Busch and J A Berger
    Drug Metabolism and Disposition March 1986, 14 (2) 147-154;
  • You have access
    Steady state kinetics of 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine.
    A D Mitchell, G D Paulson and R G Zaylskie
    Drug Metabolism and Disposition March 1986, 14 (2) 155-160;
  • You have access
    Depletion kinetics of 14C-sulfamethazine [4-amino-N-(4, 6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine.
    A D Mitchell and G D Paulson
    Drug Metabolism and Disposition March 1986, 14 (2) 161-165;
  • You have access
    Metabolism of 4,4'-methylenebis(2-chloroaniline) by canine liver and kidney slices.
    M O Manis and W E Braselton
    Drug Metabolism and Disposition March 1986, 14 (2) 166-174;
  • You have access
    Nizatidine, an H2-blocker. Its metabolism and disposition in man.
    M P Knadler, R F Bergstrom, J T Callaghan and A Rubin
    Drug Metabolism and Disposition March 1986, 14 (2) 175-182;
  • You have access
    Hepatic and muscle clearance of physostigmine in the rat.
    L K Unni and S M Somani
    Drug Metabolism and Disposition March 1986, 14 (2) 183-189;
  • You have access
    The effect of inhibitors of mitochondrial energy production on hepatic glutathione, UDP-glucuronic acid, and adenosine 3'-phosphate-5'-phosphosulfate concentrations.
    R L Dills and C D Klaassen
    Drug Metabolism and Disposition March 1986, 14 (2) 190-196;
  • You have access
    Reaction of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine.
    R B van Breemen and C C Fenselau
    Drug Metabolism and Disposition March 1986, 14 (2) 197-201;
  • You have access
    Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction.
    R E Talaat and W L Nelson
    Drug Metabolism and Disposition March 1986, 14 (2) 202-207;
  • You have access
    Multiple epoxide hydrolases in human lung.
    T M Guenthner and T A Karnezis
    Drug Metabolism and Disposition March 1986, 14 (2) 208-213;
  • You have access
    Factors affecting the biotransformation of the pesticide parathion by the isolated perfused mouse liver.
    L G Sultatos and L D Minor
    Drug Metabolism and Disposition March 1986, 14 (2) 214-220;
  • You have access
    Metabolism of unsaturated derivatives of valproic acid in rat liver microsomes and destruction of cytochrome P-450.
    K S Prickett and T A Baillie
    Drug Metabolism and Disposition March 1986, 14 (2) 221-229;
  • You have access
    Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses.
    J T Leuschner, D J Harvey, R E Bullingham and W D Paton
    Drug Metabolism and Disposition March 1986, 14 (2) 230-238;
  • You have access
    Urine flow dependence of renal clearance and interrelation of renal reabsorption and physicochemical properties of drugs.
    I Komiya
    Drug Metabolism and Disposition March 1986, 14 (2) 239-245;
  • You have access
    Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat.
    S Meloche and J G Besner
    Drug Metabolism and Disposition March 1986, 14 (2) 246-249;
  • You have access
    Pharmacokinetics of T-2 toxin and its metabolite HT-2 toxin, after intravenous administration in dogs.
    A Sintov, M Bialer and B Yagen
    Drug Metabolism and Disposition March 1986, 14 (2) 250-254;
  • You have access
    Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
    R G Dickinson, R M Kluck, B T Wood, M J Eadie and W D Hooper
    Drug Metabolism and Disposition March 1986, 14 (2) 255-262;
  • You have access
    Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    G Sgaragli, R Ninci, L Della Corte, M Valoti, M Nardini, V Andreoli and G Moneti
    Drug Metabolism and Disposition March 1986, 14 (2) 263-266;
  • You have access
    Metabolism of doxophylline by rat liver microsomes.
    G Grosa, J S Franzone and G Biglino
    Drug Metabolism and Disposition March 1986, 14 (2) 267-270;
  • You have access
    Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    P N Shaw, J Tseti, S Warburton, A Adedoyin and J B Houston
    Drug Metabolism and Disposition March 1986, 14 (2) 271-276;
  • You have access
    A new lidocaine metabolite, omega-diethylamino-2-hydroxymethyl-6-methylacetanilide.
    R Kawai, S Fujita and T Suzuki
    Drug Metabolism and Disposition March 1986, 14 (2) 277-279;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 14, Issue 2
1 Mar 1986
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Alternative P450 Splicing Redirects Human Drug Metabolism
  • Switch from CAR to PXR in the Presence of EGF
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics